发明名称 |
Methods of treating neuroendocrine tumors using frizzled-binding agents |
摘要 |
Novel methods of treating neuroendocrine tumors are provided. In one embodiment, the method comprises administering to a subject in need thereof a therapeutically effective dose of a Wnt antagonist. In one embodiment, the Wnt antagonist is an anti-FZD antibody. In another embodiment, the Wnt antagonist is a soluble FZD receptor polypeptide. In a further embodiment, the Wnt antagonist is an anti-Wnt antibody. |
申请公布号 |
US9266959(B2) |
申请公布日期 |
2016.02.23 |
申请号 |
US201314059918 |
申请日期 |
2013.10.22 |
申请人 |
ONCOMED PHARMACEUTICALS, INC. |
发明人 |
Stagg Robert Joseph;Dupont Jakob |
分类号 |
A61K39/395;C07K16/28;C07K16/30;A61K45/06;A61K39/00 |
主分类号 |
A61K39/395 |
代理机构 |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
代理人 |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
主权项 |
1. A method of treating neuroendocrine cancer, wherein the method comprises administering to a subject in need thereof a therapeutically effective amount of an anti-frizzled (FZD) receptor antibody that specifically binds two or more human FZD receptors selected from the group consisting of: FZD1, FZD2, FZD5, FZD7, and FZD8, wherein the neuroendocrine cancer is resistant to treatment with one or more of a chemotherapeutic, a somatostatin analog and a kinase inhibitor. |
地址 |
Redwood City CA US |